手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 世界医学前沿 Volume 5, Issue 8. 2023.
基于骨细胞调节机制谈铁代谢与骨质疏松
作者 : 李如 旭（, 郭海 瑞（, 卢飞 龙（
DOI: 10.12361/2705-1161-05-08-151754
全部来源
获取全文
摘要 / Abstract
研究发现铁代谢通过影响成骨细胞与破骨细胞与骨质疏松紧密联系，因此深入探索两者的细胞 调节机制有助于骨质疏松的治疗和预防。文章通过总结近年来有关铁代谢对骨稳态的影响，讨论了铁代谢在骨 质疏松中的作用，提出铁相关制剂治疗骨质疏松的前景，指出骨质疏松临床研究的潜在方向。
关键词 / Keywords
铁代谢；骨质疏松；细胞调节；骨代谢
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1] 黎淼 , 何琪 , 曾嘉旭 , 等 . 骨科相关疾病发生
  • 发展中的铁超载 [J]. 中国组织工程研究，2023,27(17):2
  • 723-2728.
  • [2] LI J, CAO F , YIN HL, et al. Ferroptosis: past,
  • present and future[J].Cell Death Dis.2020;11(2):88.
  • [3] Billesbolle C B,A. Dasgupta, P. S. Rosenberg, et
  • al. Structure of hepcidin-bound ferroportin reveals iron
  • homeostatic mechanisms[J]. Nature 586,807–811(2020).
  • [4] Pasricha S R,Tye-Din J, Muckenthaler M U,et
  • al. Iron deficiency[J].Lancet 397, 233–248 (2021).
  • [5] 张伟，李光飞，徐又佳，等 . 铁稳态与骨质疏
  • 松 [J]. 中国骨质疏松杂志，2013,19(12):1291-1295.
  • [6] Hirota K,Collins F,Rios-Arce N,An intimate
  • crosstalk between iron homeostasis and oxygen meta_xfffe_bolism regulated by the hypoxia-inducible factors (HIFs)[J].
  • Free Radic. Biol. Med.133, 118–129 (2019).
  • [7] 魏戌，刘宁，章轶立，等 . 骨质疏松症的共病
  • 研究与早期筛查 [J]. 中国全科医学，2022,25(35):4369-
  • 4374.
  • [8] 万超超，曹林忠，王多贤，等 . 成骨细胞铁
  • 代谢异常的研究进展 [J]. 中国骨质疏松杂志，2023，
  • 29(5):691-695（700）.
  • [9] Robach P,Whittow C, Aartun J,et al. Alterations
  • of systemic and muscle iron metabolism in human subjects
  • treated with low-dose recombinant erythropoietin[J].
  • Blood 113,6707–6715(2009).
  • [10] Kautz L.Engdahl C, Henning P,et al.
  • Identification of erythroferrone as an erythroid regulator of
  • iron metabolism[J].Nat. Genet.46,678–684(2014).
  • [11] Coffey R,Coudert AE，Callebert J，et al.
  • Erythroid overproduction of erythroferrone causes iron
  • overload and developmental abnormalities in mice[J].Blood
  • 139,439–451(2022).
  • [12] Mayeur C,Coudert E，Callebert J，et al. The
  • type I BMP receptor Alk3 is required for the induction of
  • hepatic hepcidin gene expression by interleukin-6[J].Blood
  • 123,2261–2268(2014).
  • [13] Hentze MW,Muckenthale MU, Galy B , et al.
  • Two to tango:regulation of Mammalian iron metabolism[J].
  • Cell 142,24–38 (2010).
  • [14] den Elzen WP,Camaschella C, et al. Plasma
  • hepcidin levels and anemia in old age. The Leiden 85-Plus
  • Study[J]. Haematologica 98, 448–454 (2013).
  • [15] Cui J,Liu Q,Sin L,et al. Osteocytes in bone
  • aging: advances, challenges, and future per-spectives[J].
  • Ageing Res.Rev.77,101608 (2022).
  • [16] Nakashima, T.Coutte F, Frémont M,et alet
  • al. Evidence for osteocyte regulation of bone homeostasis
  • through RANKL expression[J].Nat.Med.17,1231–1234
  • (2011).
  • [17] Zhang, F. Zhu Q,Xin K,et al. Metalloreductase
  • Steap3 coordinates the regulation of iron homeostasis
  • and inflammatory responses[J].Haematologica 97,1826–
  • 1835(2012).
  • [18] Dong D.Lu W,Tian S,et al.16 T high static
  • magnetic field inhibits receptor activator of nuclear factor
  • kappa-Beta ligand-induced osteoclast differentiation by
  • regulat-ing iron metabolism in Raw264.7 cells[J].Tissue
  • Eng.Regen.Med 13,2181–2190(2019).
  • [19] Xu Z,Zhu L,Jing H,et al.The regulation of iron
  • metabolism by hepcidin contributes to unloading-induced
  • bone loss[J].Bone 94,152–161(2017).
  • [20] TSAY J, YANG Z, ROSS FP , et al. Bone loss
  • caused by iron overload in a murine model: importance of
  • oxidave stress[J]. Blood. 2010;116(14):2582-2589.
  • [21] LI G F , PAN YZ, SIROIS P , et al. Iron
  • homeostasis in osteoporosis and its clinical implicaons.
  • Osteoporos Int[J].2012;23(10):2403-2408.
  • [22] CHEN B, YAN YL, LIU C, et al. Therapeuc
  • effect of deferoxamine on iron overload-induced inhibion
  • of osteogenesis in a zebrafish model[J]. Calcif Tissue
  • Int.2014;94(3):353-360.
  • [23] JOMOVA K, VALKO M. Advances in metalinduced oxidave stress and human disease[J].Toxicology.
  • 2011;283(2-3):65-87.
  • [24] JENEY V.Clinical Impact and Cellular
  • Mechanisms of Iron Overload-Associated Bone Loss[J].
  • Front Pharmacol.2017;8:77.
  • [25] Harris MM，Houtkooper LB，Stanford VA，
  • et al．Dietary iron is associated with bone mineral density
  • in healthy postmenopausal women[J].Nutr，2003，
  • 133(11):3598-3602．
  • [26] Maurer J，Harris MM，Stanford VA，et al
  • ．Dietary iron positively influences bone mineral density
  • in postmenopausal women on hormone replacement
  • therapy[J].Nutr，2005，135(4):863-869．
  • [27] Messer JG，Cooney PT，Kipp DE，et al.Iron
  • chelator deferoxamine alters iron-regulatory genes and
  • proteins and suppresses osteoblast phenotype in fetal rat
  • calvaria cells[J]. Bone，2010，46 (5):1408-1415．
  • [28] Zhou Y,Liu Q,Yang W, et al.Irp2 knockout
  • causes osteoporosis by inhibition of bone remo-deling[J].
  • Calcif.Tissue Int.104,70–78 (2019).
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号